Daito Pharmaceutical Co.,Ltd. (TSE:4577) announces a share repurchase program. Under the program, the company will repurchase up to 160 shares. The purpose of the program is treatment of fractions less than one share due to stock split.

The plan is valid till September 14, 2023.